<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04957771</url>
  </required_header>
  <id_info>
    <org_study_id>LM2019185</org_study_id>
    <nct_id>NCT04957771</nct_id>
  </id_info>
  <brief_title>Effect of Standardized Exercise on Cardiopulmonary Function in Patients With Permanent Pacemaker Implantation</brief_title>
  <official_title>Effect of Standardized Exercise on Cardiopulmonary Function in Patients With Permanent Pacemaker Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to observe the changes of cardiopulmonary endurance in patients&#xD;
      with pacemaker implantation after long-term exercise, to explore the significance of exercise&#xD;
      on patients with pacemaker implantation, and to analyze the difference of the effect of&#xD;
      exercise on cardiopulmonary endurance in patients with normal LVEF of different pacing ratios&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Actual">July 31, 2020</completion_date>
  <primary_completion_date type="Actual">July 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Parameters related to exercise cardiopulmonary assessment</measure>
    <time_frame>followed up for one year</time_frame>
    <description>VO2peak</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Pacemaker DDD</condition>
  <condition>Cardiopulmonary Endurance</condition>
  <arm_group>
    <arm_group_label>Regular exercise group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>non-regurlar exercise group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Supervise and guide regular exercise</intervention_name>
    <description>Aerobic exercise, evaluated by cardiopulmonary exercise test, 3-5 times a week</description>
    <arm_group_label>Regular exercise group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-75 years old patients with pacemaker implantation for the first time,&#xD;
&#xD;
          -  3-6 months after operation&#xD;
&#xD;
          -  stable condition,&#xD;
&#xD;
          -  independent walking ability.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cognitive impairment;&#xD;
&#xD;
          -  ICD, CRT / Crtd implanted,&#xD;
&#xD;
          -  patients with neurogenic syncope;&#xD;
&#xD;
          -  Atrial tachycardia, atrial fibrillation,&#xD;
&#xD;
          -  NYHA class II or above,&#xD;
&#xD;
          -  difficult to control hypertension;&#xD;
&#xD;
          -  Musculoskeletal disease limiting activity&#xD;
&#xD;
          -  nervous system disease,&#xD;
&#xD;
          -  severe respiratory disease,&#xD;
&#xD;
          -  Patients with acute inflammation,&#xD;
&#xD;
          -  cancer and other diseases uncontrolled.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>lijie sun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Haidian</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 27, 2021</study_first_submitted>
  <study_first_submitted_qc>July 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2021</study_first_posted>
  <last_update_submitted>July 4, 2021</last_update_submitted>
  <last_update_submitted_qc>July 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

